WuXi Biologics

Article

Sponsored Content

WuXi Biologics offers comprehensive technology platforms for the development of biologics.

WuXi Biologics offers comprehensive technology platforms for the development of biologics. The company provides global pharmaceutical and biotechnological companies a single-source solution to discover, develop, and manufacture biologics from concept to commercialization. Our services help our clients shorten the discovery and development time and lower the cost of biologics.

WuXi Biologics 

Related Content
Catalent's Flexible Fill/Finish Capabilities for Drug Products

Catalent's Flexible Fill/Finish Capabilities for Drug Products CPHI Barcelona

BioPharm International Editors
October 10th 2023
Article

Catalent provides fill/finish services across a range of product formats from clinical to commercial scale.

GPEx® Lightning Cell Line Development Technology

GPEx® Lightning Cell Line Development Technology

Catalent
July 14th 2023
Article

Shorten clinical development timeline using novel GPEx® Lightning cell line development technology.

Immediate Availability of All Protein A Resins

Immediate Availability of All Protein A Resins

Purolite
July 14th 2023
Article

Accelerate your downstream purification with high yield, high recovery & fewer cycles and a faster route to market.

Site Logo

Introducing the BIOne 10L Single-Use Bioreactor

Distek, Inc
April 1st 2023
Article

The BIOne 10L SUB is highly innovative with expanded processing capabilities, ideal for scale-down modeling, material generation, and process optimization.

Catalent Cell & Gene Therapy

Catalent's UpTempo℠ AAV Platform

Catalent
March 17th 2023
Article

CDMO Catalent’s UpTempo℠ adeno-associated viral (AAV) platform process accelerates time from gene to clinic.

2023 PDA Annual Meeting

2023 PDA Annual Meeting

Parenteral Drug Association (PDA)
February 7th 2023
Article

The 2023 PDA Annual Meeting is heading to New Orleans, LA, April 3-5.

© 2024 MJH Life Sciences

All rights reserved.